Authors
Leif Dahlberg, R Clark Billinghurst, Paul Manner, Fred Nelson, Ginette Webb, Mirela Ionescu, Agnes Reiner, Michael Tanzer, David Zukor, Jeffrey Chen, Harold E Van Wart, A Robin Poole
Publication date
2000/3
Journal
Arthritis & Rheumatism: Official Journal of the American College of Rheumatology
Volume
43
Issue
3
Pages
673-682
Publisher
John Wiley & Sons, Inc.
Description
Objective
To examine whether type II collagen cleavage by collagenase and loss of proteoglycan are excessive in human osteoarthritic (OA) articular cartilage compared with nonarthritic articular cartilage, and whether this can be inhibited by a selective synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1 [MMP‐1]).
Methods
Articular cartilage samples were obtained during surgery from 11 patients with OA and at autopsy from 5 adults without arthritis. The articular cartilage samples were cultured in serum‐free medium. A collagenase‐generated neoepitope, which reflects cleavage of type II collagen, and proteoglycan glycosaminoglycan (GAG), which predominantly reflects aggrecan release, were assayed in culture media. In addition, cultures were performed using either of 2 synthetic MMP inhibitors, both of which inhibited collagenase 2 (MMP‐8) and collagenase 3 (MMP‐13), but one of …
Total citations
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024213211620181312818231612121012129103581066